MSL
MEDP icon

Mackay Shields LLC’s Medpace MEDP Stock Holding History

Mackay Shields LLC’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,095
Closed -$3.13M – 1067
2021
Q1 		$3.13M Sell
19,095
-14,205
-43% -$2.17M 0.02% 590
2020
Q4 		$4.63M Sell
33,300
-1,300
-4% -$164K 0.03% 508
2020
Q3 		$3.87M Buy
34,600
+21,300
+160% +$2.46M 0.03% 506
2020
Q2 		$1.24M Sell
13,300
-26,579
-67% -$2.26M 0.01% 954
2020
Q1 		$2.93M Sell
39,879
-13,500
-25% -$1.17M 0.03% 513
2019
Q4 		$4.49M Sell
53,379
-200
-0.4% -$15.5K 0.03% 502
2019
Q3 		$4.5M Sell
53,579
-15,900
-23% -$1.2M 0.03% 535
2019
Q2 		$4.55M Buy
69,479
+39,413
+131% +$2.27M 0.03% 557
2019
Q1 		$1.77M Buy
30,066
+2,100
+8% +$125K 0.01% 751
2018
Q4 		$1.48M Sell
27,966
-6,634
-19% -$364K 0.01% 777
2018
Q3 		$2.07M Buy
+34,600
New +$1.89M 0.02% 703

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mackay Shields LLC's MEDP Position: Q2 2021 in Review

Mackay Shields LLC sold out of Medpace (MEDP) in Q2 2021, closing a stake of 19,095 shares — an estimated $3.13M sold.

Mackay Shields LLC first reported a position in MEDP in Q3 2018 and held it in 11 quarters. The position peaked at $4.63M in Q4 2020. 324 funds tracked by Wall St. Rank hold MEDP as of Q2 2021.

  • Mackay Shields LLC reported no remaining Medpace position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 19,095 Medpace shares in Q2 2021, an estimated $3.13M.
  • Mackay Shields LLC first reported a position in Medpace in Q3 2018 and held it in 11 quarters.
  • Mackay Shields LLC's Medpace position peaked at $4.63M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Medpace as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.